CVE:IGX IntelGenx Technologies (IGX) Stock Price, News & Analysis → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free IGX Stock Alerts C$0.58 +0.01 (+1.75%) (As of 10/6/2021) Add Compare Share Share Today's RangeC$0.58▼C$0.6050-Day RangeC$0.58▼C$0.5852-Week RangeC$0.17▼C$0.85Volume11,848 shsAverage Volume56,279 shsMarket CapitalizationC$87.32 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IntelGenx Technologies alerts: Email Address Ad Profits RunVIPs Only (Do NOT Share This)For over five decades, I've been immersed in the markets, confident I had uncovered all there was to see. But recently, while collaborating on some strategies with my son, we stumbled upon something unexpected. During one of our sessions, my son highlighted an unusual X pattern on our charts. Learn More About This Pattern About IntelGenx Technologies Stock (CVE:IGX)IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.Read More IGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IGX Stock News HeadlinesMay 17, 2024 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic AlternativesMay 17, 2024 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Thursday (IGX)May 15, 2024 | washingtonpost.comIntelGenx: Q1 Earnings SnapshotApril 8, 2024 | ca.finance.yahoo.comStocks in play: IntelGenx Corp.April 5, 2024 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Updates Status of Buprenorphine Buccal Film ANDAFebruary 20, 2024 | uk.finance.yahoo.comIntelGenx Launches Preferred Share Regulation A OfferingJanuary 11, 2024 | msn.comNVIDIA partners with Amgen to build generative AI models for drug discoveryJanuary 2, 2024 | finance.yahoo.comCHANGES TO BOARD OF DIRECTORS OF GEEKCODecember 18, 2023 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilmDecember 5, 2023 | finance.yahoo.comIntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000December 4, 2023 | finance.yahoo.comIntelGenx Announces Changes to its Board of DirectorsNovember 29, 2023 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Announces Shareholder Approval of Financing TransactionsNovember 13, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Monday (IGX)November 10, 2023 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Reports Third Quarter 2023 Financial ResultsNovember 7, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Tuesday (IGX)November 2, 2023 | finance.yahoo.comIntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to FollowOctober 21, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp flat on Friday (IGX)October 13, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp down on Thursday (IGX)October 7, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp flat on Thursday (IGX)September 19, 2023 | finance.yahoo.comIntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal FilmAugust 2, 2023 | msn.comIntelGenx Technologies (IGXT) Price Target Increased by 8.03% to 0.79July 25, 2023 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Announces a Change to its Board of DirectorsJuly 25, 2023 | finance.yahoo.comIntelGenx Provides Update on Research Collaboration Evaluating Montelukast VersaFilm® for the Treatment of Parkinson’s DiseaseMay 31, 2023 | finance.yahoo.comIntelGenx Unveils Short-Term Commercial ObjectivesMay 11, 2023 | marketwatch.com8-K: IntelGenx Technologies Corp.See More Headlines Receive IGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:IGX CUSIPN/A CIKN/A Webwww.intelgenx.com Phone514-331-7440FaxN/AEmployees48Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio164.62 Current Ratio2.77 Quick Ratio2.69 Sales & Book Value Annual SalesC$1.75 million Price / Sales49.95 Cash FlowC$0.08 per share Price / Cash Flow7.16 Book ValueC$0.05 per share Price / Book12.89Miscellaneous Outstanding Shares150,546,000Free FloatN/AMarket CapC$87.32 million OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Horst G. Zerbe (Age 74)Chairman, CEO & Chairman of Scientific Advisory Board Comp: $240.75kMr. André Godin C.A. (Age 57)CPA, CPA, CA, Pres & CFO Comp: $223.6kMs. Nadine Paiement (Age 44)Vice-Chair of Scientific Advisory Board and VP of R&D - IntelGenx Corp Comp: $140.13kDr. Dana Matzen (Age 43)VP of Bus. & Corp. Devel. of IntelGenx Corp Comp: $171.43kStephen KilmerInvestor Relations OfficerDr. Rodolphe Obeid Ph.D. (Age 41)VP of Operations - IntelGenx Corp Mr. Tommy Kenny J.D. (Age 34)L.L.B., M.Sc., VP of Intellectual Property & Legal Affairs and Gen. Counsel of IntelGenx Corp Ms. Ingrid Zerbe (Age 67)Corp. Sec. More ExecutivesKey CompetitorsTheratechnologiesTSE:THSernovaTSE:SVANovoheartCVE:NVH138267 (COM.TO)TSE:COMScythian BiosciencesCVE:SCYBView All Competitors IGX Stock Analysis - Frequently Asked Questions How have IGX shares performed in 2024? IntelGenx Technologies' stock was trading at C$0.58 at the start of the year. Since then, IGX shares have increased by 0.0% and is now trading at C$0.58. View the best growth stocks for 2024 here. What other stocks do shareholders of IntelGenx Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include IntelGenx Technologies (IGXT), Aurora Cannabis (ACB), New Age Brands (NF), Capstone Copper (CS), Hanesbrands (HBI), Tilray (TLRY), ACADIA Pharmaceuticals (ACAD), AusCann Group (AC8), Cameco (CCJ) and Baylin Technologies (BYL). How do I buy shares of IntelGenx Technologies? Shares of IGX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:IGX) was last updated on 5/25/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThis could mean the end of the U.S dollar…Colonial MetalsVIPs Only (Do NOT Share This)Profits Run[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaWrite this ticker symbol down…StocksToTrade$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyA personal note from Behind The Markets' CEO Dylan Jovine...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IntelGenx Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.